Estrogen Receptor Positive Breast Cancer Recruiting Phase 2 Trials for Bevacizumab (DB00112)

Also known as: Oestrogen receptor positive breast cancer

IndicationStatusPhase
DBCOND0049177 (Estrogen Receptor Positive Breast Cancer)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03395899Pre-operative Immunotherapy Combination Strategies in Breast CancerOther